Stockreport

Astria Stockholders Vote to Approve Acquisition by BioCryst

Astria Therapeutics, Inc.  (ATXS) 
PDF BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria’s stockholders held on January 21, 2026, Astr [Read more]